Skip to content

Clinical trials

Completed Lymphoma, B-Cell, Marginal Zone trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Status: Completed Country / region: South Korea Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20092
20141
20151
20161
20192
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center3
AstraZeneca1
BeiGene1
Boryung Pharmaceutical Co., Ltd1
Dong-A University Hospital1
Janssen Research & Development, LLC1
Loxo Oncology, Inc.1
Prelude Therapeutics1
Seoul National University Hospital1
Xencor, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone12
Lymphoma, Follicular8
Leukemia, Lymphocytic, Chronic, B-Cell7
Lymphoma, Mantle-Cell7
Lymphoma, Large B-Cell, Diffuse6
Lymphoma, B-Cell5
Lymphoma, Non-Hodgkin5
Recurrence5
Waldenstrom Macroglobulinemia5
Burkitt Lymphoma4

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.